400900-01-8

Upstream product

• 611396-51-1 methyl 4-sulfoaminobenzoate sodium salt 
• 619-45-4 4-methoxycarbonyl aniline 

Downstream Products

• 259794-34-8 (+/-)-methyl 4-[({[1-(methoxycarbonyl)-2-(naphthalen-2-yl)ethyl]amino}sulfonyl)amino]benzene-1-carboxylate 
• 259794-35-9 (+/-)-methyl 4-[({[1-(methoxycarbonyl)-3-phenylpropyl]amino}sulfonyl)amino]benzene-1-carboxylate 
• 259794-36-0 (+/-)-methyl 4-{[({1-(methoxycarbonyl)-2-[4-(phenylmethoxy)phenyl]ethyl}amino)sulfonyl]amino}benzene-1-carboxylate 
• 900509-33-3 C₂₈H₂₈N₆O₈S₂ 
• 1179329-57-7 1-{2-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxo-imidazolidin-1-ylmethyl]-5-fluorophenyl}-3-(4-methoxycarbonyl-phenyl)sulfamide 
• 259794-44-0 (+/-) 4-(4-{[4-(phenylmethoxy)phenyl]methyl}-1,1,3-trioxo-1λ⁶,2,5-thiadiazolan-2-yl)benzene-1-carboxamide 
• 259794-40-6 (+/-)-methyl 4-(4-{[4-(phenylmethoxy)phenyl]methyl}-1,1,3-trioxo-1λ⁶,2,5-thiadiazolan-2-yl)benzoate 
• 259794-38-2 (+/-)-methyl 4-[4-(naphthalen-2-ylmethyl)-1,1,3-trioxo-1λ⁶,2,5-thiadiazolan-2-yl]benzoate 
• 259794-39-3 (+/-)-methyl 4-[4-(2-phenylethyl)-1,1,3-trioxo-1λ⁶,2,5-thiadiazolan-2-yl]benzoate 
• 259794-37-1 (+/-)-methyl 4-[4-(phenylmethyl)-1,1,3-trioxo-1λ⁶,2,5-thiadiazolan-2-yl]benzoate 
• 259794-33-7 (+/-)-methyl 4-[({[1-(methoxycarbonyl)-2-phenylethyl]amino}sulfonyl)amino]benzene-1-carboxylate 

Relevant academic research and scientific papers

Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Inhibitors of HCV NS5B polymerase: Synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides

Substituted N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides were investigated as inhibitors of genotype 1 HCV polymerase. Structure-activity relationship patterns for this class of compounds are discussed.

Synthesis of 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and evaluation of their affinity for MHC class-II proteins

1,2,5-Thiadiazolidin-3-one 1,1-dioxide derivatives (±)-1a-d and (±)-2 were designed by molecular modeling as MHC (major histocompatibility complex) class-II inhibitors. They were prepared from the unsymmetrically N,N'- disubstituted acyclic sulfamides (±)